Diagnos Laboratorium Utama Tbk. vs Gunung Raja Paksi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Gunung Raja Paksi Tbk. trades at Rp296 (market cap 3.56T, 344.8K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 11.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 344.8K). Which is the better fit depends on your goals.
| DGNS | GGRP | |
|---|---|---|
Market Cap | 310.75B | 3.56T |
Volume | 963.6K | 344.8K |
Lot | 9.64K | 3.45K |
Turnover | 217.67M | 101.61M |
Average Price | 225.89 | 294.7 |
Value | 217.67M | 101.61M |
Indicative Equilibrium Price | 226 | 296 |
Indicative Equilibrium Volume | 1K | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →